Cargando…

Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A

The Marburg variant of MS is a rare variant that leads to a severe clinical course, with a high rate of mortality or severe residual deficits and unclear pathophysiology. A 20-year-old female patient, presented at the hospital emergency with left inferior limb paresis and visual blurring. The neurol...

Descripción completa

Detalles Bibliográficos
Autores principales: Araújo, Victor Oliveira, Marcelino, Paulo Filho Soares, Rabelo, Samuel Ramos, Junior, Fabio Antonio Serra de Lima, Teixeira, Vitor Gil Gonçalves, Eisele, Roberto Rocha, Eisele, Afonso Rocha, de Carvalho, João Pedro Serenario Ferreira, Filho, Luciano Barroso de Albuquerque, de Medeiros, Sara Diógenes Peixoto, Oliveira, Leandro Freitas, Claudino dos Santos, Julio Cesar, Júnior, Euldes Mendes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438400/
https://www.ncbi.nlm.nih.gov/pubmed/36068807
http://dx.doi.org/10.1016/j.radcr.2022.06.090
_version_ 1784781821328752640
author Araújo, Victor Oliveira
Marcelino, Paulo Filho Soares
Rabelo, Samuel Ramos
Junior, Fabio Antonio Serra de Lima
Teixeira, Vitor Gil Gonçalves
Eisele, Roberto Rocha
Eisele, Afonso Rocha
de Carvalho, João Pedro Serenario Ferreira
Filho, Luciano Barroso de Albuquerque
de Medeiros, Sara Diógenes Peixoto
Oliveira, Leandro Freitas
Claudino dos Santos, Julio Cesar
Júnior, Euldes Mendes
author_facet Araújo, Victor Oliveira
Marcelino, Paulo Filho Soares
Rabelo, Samuel Ramos
Junior, Fabio Antonio Serra de Lima
Teixeira, Vitor Gil Gonçalves
Eisele, Roberto Rocha
Eisele, Afonso Rocha
de Carvalho, João Pedro Serenario Ferreira
Filho, Luciano Barroso de Albuquerque
de Medeiros, Sara Diógenes Peixoto
Oliveira, Leandro Freitas
Claudino dos Santos, Julio Cesar
Júnior, Euldes Mendes
author_sort Araújo, Victor Oliveira
collection PubMed
description The Marburg variant of MS is a rare variant that leads to a severe clinical course, with a high rate of mortality or severe residual deficits and unclear pathophysiology. A 20-year-old female patient, presented at the hospital emergency with left inferior limb paresis and visual blurring. The neurologic exam showed complete and proportionate left hemiparesis with pyramidal signs and clonus, loss of proprioception and vibration in lower limbs, tactile, and painful hypoesthesia on the left side. This report describes a rare case of Marburg variant associated with COVID-19 infection.
format Online
Article
Text
id pubmed-9438400
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94384002022-09-02 Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A Araújo, Victor Oliveira Marcelino, Paulo Filho Soares Rabelo, Samuel Ramos Junior, Fabio Antonio Serra de Lima Teixeira, Vitor Gil Gonçalves Eisele, Roberto Rocha Eisele, Afonso Rocha de Carvalho, João Pedro Serenario Ferreira Filho, Luciano Barroso de Albuquerque de Medeiros, Sara Diógenes Peixoto Oliveira, Leandro Freitas Claudino dos Santos, Julio Cesar Júnior, Euldes Mendes Radiol Case Rep Case Report The Marburg variant of MS is a rare variant that leads to a severe clinical course, with a high rate of mortality or severe residual deficits and unclear pathophysiology. A 20-year-old female patient, presented at the hospital emergency with left inferior limb paresis and visual blurring. The neurologic exam showed complete and proportionate left hemiparesis with pyramidal signs and clonus, loss of proprioception and vibration in lower limbs, tactile, and painful hypoesthesia on the left side. This report describes a rare case of Marburg variant associated with COVID-19 infection. Elsevier 2022-09-02 /pmc/articles/PMC9438400/ /pubmed/36068807 http://dx.doi.org/10.1016/j.radcr.2022.06.090 Text en © 2022 Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Araújo, Victor Oliveira
Marcelino, Paulo Filho Soares
Rabelo, Samuel Ramos
Junior, Fabio Antonio Serra de Lima
Teixeira, Vitor Gil Gonçalves
Eisele, Roberto Rocha
Eisele, Afonso Rocha
de Carvalho, João Pedro Serenario Ferreira
Filho, Luciano Barroso de Albuquerque
de Medeiros, Sara Diógenes Peixoto
Oliveira, Leandro Freitas
Claudino dos Santos, Julio Cesar
Júnior, Euldes Mendes
Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A
title Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A
title_full Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A
title_fullStr Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A
title_full_unstemmed Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A
title_short Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A
title_sort tumefactive demyelination after covid-19 successfully treated with betainterferon 1a
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438400/
https://www.ncbi.nlm.nih.gov/pubmed/36068807
http://dx.doi.org/10.1016/j.radcr.2022.06.090
work_keys_str_mv AT araujovictoroliveira tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a
AT marcelinopaulofilhosoares tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a
AT rabelosamuelramos tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a
AT juniorfabioantonioserradelima tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a
AT teixeiravitorgilgoncalves tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a
AT eiselerobertorocha tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a
AT eiseleafonsorocha tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a
AT decarvalhojoaopedroserenarioferreira tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a
AT filholucianobarrosodealbuquerque tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a
AT demedeirossaradiogenespeixoto tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a
AT oliveiraleandrofreitas tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a
AT claudinodossantosjuliocesar tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a
AT junioreuldesmendes tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a